10-KPeriod: FY2023

HCA Healthcare, Inc. Annual Report, Year Ended Dec 31, 2023

Filed February 16, 2024For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) reported robust revenue growth in its 2023 annual report, with total revenues reaching $64.968 billion, a 7.9% increase over 2022. This growth was primarily driven by a 4.9% rise in equivalent admissions and a 2.8% increase in revenue per equivalent admission. Despite this top-line expansion, net income attributable to HCA Healthcare decreased to $5.242 billion from $5.643 billion in the prior year, impacted by the absence of significant facility sale gains recorded in 2022 and increased operating expenses, particularly in 'other operating expenses' which rose as a percentage of revenue. The company continues to invest heavily in its operations, with capital expenditures reaching $4.744 billion (excluding acquisitions) in 2023, indicating a commitment to enhancing facilities and services. HCA also returned significant capital to shareholders through share repurchases totaling $3.811 billion and dividends of $661 million in 2023. The company's strategic focus remains on expanding its presence in existing markets, achieving operational excellence, and recruiting top talent, positioning it for continued growth despite a competitive landscape and ongoing healthcare industry reforms.

Financial Highlights

46 data points
Beta

Revenue

$64.97B

Net Income

$5.24B

8.1% Net Margin

EPS (Diluted)

$18.97

Total Assets

$56.21B

Cash & Equivalents

$935.00M

Free Cash Flow

$4.69B

Financial Statements
Beta
Revenue$64.97B
Operating Expenses$57.26B
Interest Expense$1.94B
Net Income$5.24B
EPS (Basic)$19.25
EPS (Diluted)$18.97
Shares Outstanding (Basic)272.40M
Shares Outstanding (Diluted)276.41M

Key Highlights

  • 1HCA Healthcare reported a 7.9% increase in consolidated revenues to $64.968 billion for 2023, driven by higher patient volumes and revenue per patient.
  • 2Net income attributable to HCA Healthcare decreased by 7.1% to $5.242 billion in 2023, primarily due to the absence of significant gains from facility sales recognized in 2022 and increased operating expenses.
  • 3Capital expenditures were substantial at $4.744 billion (excluding acquisitions) in 2023, reflecting ongoing investment in facilities and services.
  • 4The company returned $3.811 billion to shareholders through share repurchases and paid $661 million in dividends during 2023.
  • 5HCA Healthcare operated 186 hospitals and 124 freestanding surgery centers at the end of 2023, indicating a broad operational footprint.
  • 6The company faces significant operating risks including labor shortages, competition, regulatory changes, and cybersecurity threats, which it actively manages through various initiatives.
  • 7Geographic concentration in Florida and Texas exposes HCA to specific state-level economic, regulatory, and public health conditions.

Frequently Asked Questions

In 2023, HCA Healthcare reported consolidated revenues of $64.968 billion, an increase of 7.9% from 2022. Net income attributable to HCA Healthcare was $5.242 billion, a decrease of 7.1% from $5.643 billion in 2022. This decline was largely due to the absence of significant gains from facility sales that were recorded in the prior year, as well as increased operating expenses.

HCA Healthcare returned significant capital to shareholders in 2023 through share repurchases totaling $3.811 billion and dividend payments of $661 million. The company also has ongoing share repurchase authorization and declared a quarterly dividend in January 2024.

HCA Healthcare faces several key risks, including intense competition from other healthcare providers, labor shortages impacting staffing and costs, dependence on government reimbursement programs (Medicare and Medicaid), evolving healthcare regulations, cybersecurity threats, and significant indebtedness. The company's concentration of facilities in Florida and Texas also makes it sensitive to conditions in those specific states.

HCA Healthcare's growth strategy focuses on expanding its presence in existing markets, achieving industry-leading clinical and operational performance, recruiting and retaining skilled healthcare professionals, leveraging economies of scale, and pursuing a disciplined development strategy through selective acquisitions and facility development. Investments in clinical systems, digital capabilities, and innovative care models are also key components of its strategy.